(Q53226580)

12 May 2018

title

Vascular nitric oxide may lessen Alzheimer's risk. (English)

1 reference

12 May 2018

author

Mark Frederick McCarty

series ordinal

1

object named as

McCarty MF

1 reference

12 May 2018

publication date

1 December 1998

1 reference

12 May 2018

published in

Medical Hypotheses

1 reference

12 May 2018

volume

51

1 reference

12 May 2018

issue

6

1 reference

12 May 2018

page(s)

465-476

1 reference

12 May 2018

Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Hyperinsulinaemia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Risk of dementia among persons with diabetes mellitus: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

15-year longitudinal study of blood pressure and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Nitric oxide release accounts for insulin's vascular effects in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Estrogen and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Reduced nitric oxide responsive soluble guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Relative sparing of nitric oxide synthase–containing neurons in the hippocampal formation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

1 reference

7 January 2021

The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Nitric Oxide as a Potential Bridge Between the Metabolic and Vascular Hypotheses of Diabetic Neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of beta-amyloid precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

The secreted form of the Alzheimer's beta-amyloid precursor protein stimulates a membrane-associated guanylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Amyloid beta-protein fragment 25-35 causes activation of cytoplasmic calcium in neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Vitamin E protects nerve cells from amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Hydrogen peroxide mediates amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Excitatory amino acids and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Calcium as sculptor and destroyer of neural circuitry

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2+ influx in cultured hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Hippocampal neurons predisposed to neurofibrillary tangle formation are enriched in type II calcium/calmodulin-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Two types of amyloid precursor protein (APP) mRNA in rat glioma cell lines: upregulation via a cyclic AMP-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Cyclic GMP depresses hippocampal Ca2+ current through a mechanism independent of cGMP-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Purification and partial characterization of membrane-associated type II (cGMP-activatable) cyclic nucleotide phosphodiesterase from rabbit brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Is NO an endogenous antiatherogenic molecule?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Superoxide and nitric oxide cooperation in hypoxia/reoxygenation-induced neuron injury

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

NMDA-dependent superoxide production and neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Cyclic GMP and cell death in rat cerebellar slices

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Nitric oxide synthases in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Interference of phorbolesters with endothelium-dependent vascular smooth muscle relaxation.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

A phorbol ester inhibits the release of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Superoxide anion release by human endothelial cells: synergism between a phorbol ester and a calcium ionophore

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Modulation of hormone-sensitive phospholipase C

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Protein kinase C modulates receptor-independent activation of endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Regulation of endothelial constitutive nitric oxide synthase by protein kinase C.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Dietary potassium and stroke-associated mortality. A 12-year prospective population study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

High potassium diets markedly protect against stroke deaths and kidney disease in hypertensive rats, a possible legacy from prehistoric times

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

High potassium diets protect against dysfunction of endothelial cells in stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

High potassium diet augments endothelium-dependent relaxations in the Dahl rat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Potassium preserves endothelial function and enhances aortic compliance in Dahl rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Potassium and blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Potassium inhibits free radical formation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Effects of Potassium on Blood Pressure Control

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Does potassium supplementation lower blood pressure? A meta-analysis of published trials

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Effect of ouabain on endothelium-dependent relaxation of human resistance arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Amelioration by L-arginine of a dysfunctional arginine/nitric oxide pathway in diabetic endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Vascular effects of L-arginine: anything beyond a substrate for the NO-synthase?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Heparin inhibits endothelin-1 and proto-oncogene c-fos gene expression in cultured bovine endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Effect of heparin on endothelin-1 production by cultured human endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Glucosamine may retard atherogenesis by promoting endothelial production of heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Extracellular superoxide dismutase in vessels and airways of humans and baboons.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Reported anti atherosclerotic activity of silicon may reflect increased endothelial synthesis of heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

The inhibitory effects of tea polyphenols (flavan-3-ol derivatives) on Cu2+ mediated oxidative modification of low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Possible contribution of green tea drinking habits to the prevention of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Antioxidant flavonols and coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Vitamin E suppresses diacylglycerol (DAG) level in thrombin-stimulated endothelial cells through an increase of DAG kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Effects of dietary supplementation with cod-liver oil on endothelium-dependent responses in porcine coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Chronic exposure of cultured endothelial cells to eicosapentaenoic acid potentiates the release of endothelium-derived relaxing factor(s).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Comparative effects of dietary fish oil and carbohydrate on plasma lipids and hepatic activities of phosphatidate phosphohydrolase, diacylglycerol acyltransferase and neutral lipase activities in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Inhibition of apolipoprotein secretion and phosphatidate phosphohydrolase activity by eicosapentaenoic and docosahexaenoic acids in the perfused rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Evidence for mechanisms of the hypotriglyceridemic effect of n − 3 polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Cardioprotection by angiotensin converting enzyme inhibitors--the experimental evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Endothelium-derived relaxing factors and converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Maintenance of vascular integrity: role of nitric oxide and other bradykinin mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Molecular responses of endothelial tissue to kinins

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Pathogenetic factors in hypertension. Endothelial factors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Glial cytokines in Alzheimer's disease: Review and pathogenic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Interleukin-1 stimulates the beta-amyloid precursor protein promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Dietary marine lipids suppress continuous expression of interleukin-1 beta gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Magnesium gates glutamate-activated channels in mouse central neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Effect of taurine on depolarizations induced by L-glutamate and other excitatory amino acids in the isolated spinal cord of the frog

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

A role for taurine in the maintenance of homeostasis in the central nervous system during hyperexcitation?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Taurine- and penicillin-induced epileptic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

The Current Status of Taurine in Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Taurine-induced increase of the Cl-conductance of cerebellar Purkinje cell dendrites in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Taurine in hippocampus: localization and postsynaptic action

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Complementary vascular-protective actions of magnesium and taurine: a rationale for magnesium taurate

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Memory improvement following induced hyperinsulinemia in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Diphenylhydantoin protects against hypoxia-induced impairment of hippocampal synaptic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Phenytoin protects against hypoxia-induced death of cultured hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Phenytoin reduces neonatal hypoxic-ischemic brain damage in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Phenytoin pretreatment prevents hypoxic-ischemic brain damage in neonatal rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Anticonvulsants attenuate amyloid beta-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Diphenylhydantoin attenuates hypoxia-induced release of [3H]glutamate from rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

K+ channel openers protect hippocampal neurons against oxidative injury and amyloid beta-peptide toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

Potassium channel openers: pharmacological and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2898%2990066-4

7 January 2021

10.1016/S0306-9877(98)90066-4

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018